Draft political declaration of the General Assembly high-level meeting on antimicrobial resistance

We, the heads of state and government and representatives of countries and governments, in accordance with General Assembly resolution 70/183, which decided to hold a high-level meeting on antimicrobial resistance in 2016, were held at the United Nations in New York on September 21, 2016 Headquarters meeting:1.
Reaffirm the World Health Organization’s Global Action on Antimicrobial Resistance, which was developed in collaboration with the Food and Agriculture Organization of the United Nations and the World Organization for Animal Health, and later adopted by the Food and Agriculture Organization of the United Nations and the World Organization for Animal Health.
Plan 1 and its five overarching strategic goals are the blueprint for solving the problem of antimicrobial resistance;2.
It also reaffirms that the 2030 Agenda for Sustainable Development provides a framework for ensuring healthy lives, and reviews the prevention and treatment of malaria, HIV/ Commitment to AIDS, tuberculosis, hepatitis, Ebola virus disease and other infectious diseases and epidemics, including addressing the growing problem of antimicrobial resistance and combating neglected diseases that particularly affect developing countries, while reaffirming antimicrobial resistance Drug resistance poses a challenge to the sustainability and effectiveness of public health responses to these and other diseases, as well as achievements in the field of health and development and the realization of the 2030 Agenda;3.
Recognize bacteria, viruses, and parasites And fungal microbes have developed resistance to antimicrobial drugs that have previously been effective in treating infections, mainly due to the improper use of antimicrobial drugs in public health, animal, food, agriculture and aquaculture sectors, and the inability to obtain health care services, including the inability to use diagnostics and Laboratory capacity, and antimicrobial drug residues in soil, crops and water
.
In the broader scope of antimicrobial resistance, antibiotic resistance is different from other drugs, including those used to treat tuberculosis.
It is the most serious and urgent global risk and needs to be increased at the international, national and regional levels.
Focus on and enhance consistency;4.
Also acknowledged that due to the resistance of antimicrobial drugs, many achievements in the 20th century, especially the reduction of infectious diseases and mortality through social and economic development, access to health care services, and high-quality, safe, effective and affordable Medicines, personal hygiene, safe drinking water and environmental sanitation, disease prevention (including immunizations) in communities and health care institutions, nutrition and healthy food, advances in human and veterinary medicine, and the introduction of new antimicrobial drugs and other drugs have all been severely affected.
Challenges;5.
Acknowledge that the above achievements are now severely challenged by antimicrobial resistance.
These achievements include the establishment of a resilient health system and the gradual realization of universal health care goals, HIV and sexually transmitted infections, tuberculosis and malaria, and community and health Other acquired infection treatment programs in health care institutions, the results of infection prevention and control in communities and health care institutions, the advancement of agriculture and animal husbandry that help ensure the maintenance of food quality, and the prevention and control of infectious diseases in veterinary medicine; 　　6.
Because antimicrobial drug resistance against the most vulnerable to serious life-threatening infections vulnerable, especially women, newborns, patients with certain chronic diseases or accept the alternative protection measures chemotherapy or surgery has decreased; 　　7.
Concerned about the realization that everyone is entitled to the highest attainable standard of physical and mental health, and that millions of people have access to health care services and high-quality, safe, effective and affordable antimicrobial drugs, food, and clean water Health and a healthy environment is still a distant goal, especially in developing countries; 　　8.
It is also noted with concern that although the current lack of access to health care services and antimicrobial drugs in developing countries causes more deaths than antimicrobial drugs Drug-induced deaths, but without an effective “integrated health” approach and other multi-sectoral cooperation and actions, non-antimicrobial drug resistance is expected to cause millions of deaths worldwide, and it will be harmful to society, economy, and society.
Have a huge impact on global public health;　　9.
Confirm that the key to antimicrobial resistance is the prevention and control of human and animal infections, including immunization, antimicrobial resistance monitoring and supervision; environmental sanitation, safe and clean water, and a healthy environment; investing in A strong health system that popularizes universal health care; promotes the availability of existing and new high-quality, safe, effective and affordable antimicrobial drugs based on diagnostic tests where possible; continuous research and development of new antimicrobial drugs and alternative drugs; rapid Diagnostic tests, vaccines and other important technologies, interventions and therapies; promotion of affordable and accessible health services; and addressing the problem of insufficient investment in research and development, including rewarding innovation and improving public health outcomes, especially in the area of ​​antibiotics ; 　　10.
Recognizing also solve the problem of antimicrobial drug resistance overriding principle is to promote within the "integrated health" approach and framework for the protection of human health, emphasizing the human, animal and environmental health are interrelated, the need for concerted, comprehensive and integrated Multi-sectoral actions and in this regard: 　　(a) It is also recognized that effective antimicrobial drugs and their prudent use are a global public good.
To solve the problem of antimicrobial resistance, people must be able to use an effective and resilient health system; And when necessary to obtain high-quality, safe, effective and affordable antimicrobial drugs and other technologies, as well as healthy food and the environment; 　　(b) emphasized that in order to better understand antimicrobial resistance, support for high-quality, safe, and Effective and affordable antimicrobial drugs, especially the research and development of new antibiotics and alternative therapies, vaccines and diagnostics, require basic and applied innovative research and development, including research and development in microbiology, epidemiology, traditional medicine and Research and development in the fields of herbal medicine and social and behavioral sciences; 　　(c) It is also emphasized that all research and development efforts should be demand-driven, evidence-based, and follow the principles of affordability, effectiveness and efficiency as well as the principles of fairness.
And should be considered a joint responsibility
.
In this regard, we recognize the need to decouple the investment costs of antimicrobial resistance research and development from sales prices and sales volumes in order to promote fair access to affordable new drugs, diagnostic tools, vaccines, and research and development.
Other achievements of the company welcome innovation, research and development models to provide effective solutions to the challenges posed by antimicrobial resistance, including programs that promote further investment in research and development; including governments, industry, non-governmental organizations and academics All relevant stakeholders, including the community, should continue to seek to support innovative models that address a unique set of challenges posed by antimicrobial resistance, including the need to use antimicrobial drugs appropriately and rationally, while facilitating access to affordable drugs; 　　(d) It is also emphasized that making existing and new antimicrobial drugs, vaccines and diagnostic methods affordable and accessible should be a global priority, and should also be based on the World Health Organization’s public health, innovation and intellectual property rights The global strategy and action plan take into account the needs of all countries, while taking into account the internationally agreed follow-up process; 　　(e) Improve the monitoring and supervision of antimicrobial resistance and the use of antimicrobial drugs to guide decision-making and coordinate with industry and agriculture.
Cooperate with stakeholders such as the aquaculture industry, local authorities and hospitals to reduce antimicrobial drug residues in soil, crops and water; 　　(f) Strengthen capacity building, transfer technology under mutually agreed terms, control and prevent antimicrobial resistance Technical assistance and cooperation, international cooperation, and funding to support the formulation and implementation of national action plans in terms of drug properties, including supervision and monitoring, strengthening of health systems, and research and regulatory capabilities, but must not harm health, especially in low- and middle-income countries Health should not cause obstacles to access to health services; 　　(g) Acknowledge that in order to increase people’s awareness and understanding of antimicrobial resistance and all the issues involved, it is necessary to share good practices and research results with the media, countries and multi-sectors Acting bodies cooperate and provide sufficient funds for these activities of various departments; 　　11.
It is recognized that the conditions and priorities of each country should be taken into consideration at all levels, and relevant government departments should also be involved in the formulation and implementation of multi-sectoral national action plans, policies, and Regulations and regional initiatives, taking into account national conditions, legislation and judicial responsibilities;　　12.
Therefore, we commit to work at the national, regional and global levels in order to: 　　(a) In accordance with World Health Assembly Resolution 68.
7, and in accordance with the “Integrated Health” approach and the global action on antimicrobial resistance The plan, including its five overarching strategic goals, develops multi-sectoral national action plans, programs and policy initiatives with a view to adopting national measures to strengthen the use of appropriate antibiotics for humans and animals
.
In order to support the implementation of these plans, national and international collaboration is required to assess resource needs, and provide continuous technical and financial investment for joint research, laboratory and regulatory capabilities, and professional education and training to protect human health, animal health, well-being, and Environment; 　　(b) Mobilize sufficient, predictable and sustainable capital, human and financial resources and investment through national, bilateral and multilateral channels, support the formulation and implementation of national action plans, and support the research and development of existing and new antimicrobial agents Drugs, diagnostic methods, vaccines and other technologies, and strengthen related infrastructure, including interaction and collaboration with multilateral development banks and traditional and voluntary innovative financing and investment mechanisms in accordance with government priorities and local needs, while ensuring public investment returns; 　　(c) Take steps to ensure that, as appropriate, the development and strengthening of effective human and animal antimicrobial preservation, use and distribution of supervision, monitoring and regulatory frameworks are included in the national action plan, implemented in accordance with national conditions and in accordance with international commitments; 　　(d) Initiate, increase and continue to carry out antimicrobial drug resistance awareness and increase understanding activities in order to involve different audiences and encourage them to change their behaviors, promote evidence-based prevention, infection control and sanitation programs, and optimize antimicrobial drugs for humans and animals The use of methods, appropriate prescriptions for medical professionals, the active participation of patients, consumers and the public, as well as human and animal health professionals, as well as professional education, training and certification of medical, veterinary and agricultural workers, and consider adopting Innovative methods to increase consumer awareness while paying attention to local conditions and needs;　　(e) Support the use of a multisectoral “integrated health” approach to address antimicrobial resistance, including working with relevant stakeholders such as civil society, industry, small and medium-sized enterprises, research institutions, and academia to develop public health Driven capacity building activities, innovative public-private partnerships, incentives and funding initiatives to promote access to high-quality, safe, effective and affordable new medicines and vaccines, especially antibiotics and other alternative therapies and medicines for antimicrobial therapy , As well as other mixed therapies, vaccines and diagnostic tests; 　　13.
Urge the World Health Organization to work with the Food and Agriculture Organization of the United Nations and the World Animal Health Organization to determine a global development and management framework in accordance with the requirements of Health Assembly Resolution 68.
7.
A global action plan on antimicrobial resistance to support the development, control, distribution and appropriate use of new antimicrobial drugs, diagnostic tools, vaccines and other interventions, while protecting existing antimicrobial drugs, taking into account all countries The need to promote affordable existing and new antimicrobial drugs and diagnostic tools; 　　14.
Urge the World Health Organization and the Food and Agriculture Organization of the United Nations, the World Organization for Animal Health, regional and multilateral development banks, including the World Bank and relevant United Nations agencies And other intergovernmental organizations as well as civil society and relevant multisectoral stakeholders to support the development and implementation of national action plans and antimicrobial resistance activities at the national, regional and global levels as appropriate; 　　15.
Requests the Secretary-General and the World Health Organization , The Food and Agriculture Organization of the United Nations and the World Organization for Animal Health in consultation to establish an ad hoc inter-agency coordination group, co-chaired by the General Office of the Secretary-General and the World Health Organization.
The method provides practical guidance to ensure that sustained and effective global action is taken to solve the problem of antimicrobial resistance.
It also requests the Secretary-General to take into account the global action plan on antimicrobial resistance, which will be proposed before the 73rd session of the General Assembly A report describing the implementation of this declaration, further developments, and recommendations made by the ad hoc inter-agency group, including options for improving coordination, for consideration by Member States
.